Medicare Enrolled
Dr. Vladimir Curkovic, MD
Cardiovascular Disease · Zephyrhills, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Curkovic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Curkovic? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Curkovic
Dr. Vladimir Curkovic is a cardiovascular disease in Zephyrhills, FL, with 19 years in practice. Based on federal Medicare data, Dr. Curkovic performed 8,833 Medicare services across 4,682 unique beneficiaries.
Between the years covered by Open Payments, Dr. Curkovic received a total of $12,022 from 46 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Curkovic is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $12,022 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,833
Medicare services
Top 9% in FL for cardiovascular disease
4,682
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~465 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 993 | $28 | $93 |
| Electrocardiogram (EKG), 12-lead | 857 | $11 | $43 |
| Regadenoson injection (Lexiscan) for heart stress test | 764 | $44 | $144 |
| Office visit, established patient (30-39 min) | 752 | $95 | $273 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 694 | $20 | $68 |
| Echocardiogram, transthoracic | 650 | $135 | $510 |
| Remote pacemaker/defibrillator monitoring, 90 days | 586 | $16 | $62 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 535 | $346 | $897 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 334 | $8 | $37 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 329 | $17 | $62 |
| Remote pacemaker monitoring, 90 days | 328 | $23 | $79 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 304 | $20 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 284 | $45 | $177 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 267 | $329 | $1,178 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 266 | $28 | $113 |
| Programming of dual lead pacemaker system | 182 | $54 | $162 |
| Evaluation of implantable heart and blood vessel monitoring system | 146 | $32 | $105 |
| New patient office visit (45-59 min) | 126 | $125 | $415 |
| Office visit, established patient, complex (40-54 min) | 98 | $136 | $366 |
| Ultrasound of both sides of head and neck blood flow | 90 | $134 | $496 |
| Programming of dual lead implantable defibrillator system | 72 | $69 | $212 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $45 | $219 |
| Programming of single lead pacemaker system | 34 | $43 | $138 |
| Programming of multiple lead implantable defibrillator system | 34 | $72 | $230 |
| Programming of single lead implantable defibrillator system | 31 | $54 | $168 |
| Programming of cardiac rhythm monitor system | 15 | $46 | $121 |
| New patient office visit, complex (60-74 min) | 15 | $161 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.7% high complexity
15.9% medium
59.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,022
Total received (2018-2024)
Avg $1,717/year across 7 years
Top 21% in FL for cardiovascular disease
46
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,511 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$511 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,097
2023$1,996
2022$1,946
2021$1,887
2020$1,036
2019$1,128
2018$1,931
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,160
BIOTRONIK INC.
$929
CVRx, Inc.
$908
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$801
Janssen Pharmaceuticals, Inc
$789
Amgen Inc.
$711
Boehringer Ingelheim Pharmaceuticals, Inc.
$704
Novartis Pharmaceuticals Corporation
$674
E.R. Squibb & Sons, L.L.C.
$587
AstraZeneca Pharmaceuticals LP
$520
Astellas Pharma US Inc
$502
Boston Scientific Corporation
$434
Medtronic, Inc.
$351
PFIZER INC.
$329
Impulse Dynamics (USA) Inc.
$316
Esperion Therapeutics, Inc.
$215
AtriCure, Inc.
$200
Lexicon Pharmaceuticals, Inc.
$177
SANOFI-AVENTIS U.S. LLC
$170
Endologix LLC
$140
Actelion Pharmaceuticals US, Inc.
$128
Bardy Diagnostics, Inc.
$112
Merck Sharp & Dohme Corporation
$111
Amarin Pharma Inc.
$104
Edwards Lifesciences Corporation
$98
iRhythm Technologies, Inc.
$98
BOSTON SCIENTIFIC CORPORATION
$97
Alnylam Pharmaceuticals Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$69
Allergan Inc.
$62
Chiesi USA, Inc.
$62
Gilead Sciences, Inc.
$53
Medtronic Vascular, Inc.
$48
Kestra Medical Technology Services, Inc.
$48
ATRICURE, INC.
$29
Inari Medical, Inc.
$28
SCPHARMACEUTICALS INC.
$26
EISAI INC.
$22
Novo Nordisk Inc
$22
Lundbeck LLC
$22
AngioDynamics, Inc.
$20
Kiniksa Pharmaceuticals International, plc
$18
Preventice Services, LLC
$16
CHIESI USA, INC.
$14
Kowa Pharmaceuticals America, Inc.
$14
United Therapeutics Corporation
$13
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ALPHAVAC · AMVIA EDGE · AVEIR · Acticor · Acticor 7 VR-T DX · Aduhelm · Alto Abdominal Stent Graft System · Arcalyst · Assure WCD · Assurity Pacemaker · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CLEVIPREX · CONFIRM RX · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · Fortify Assura · GENERAL STRUCTURAL HEART · General - Therapies · ICDs · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · ORENITRAM · Optimizer · Ozempic · PAMIRA · PRADAXA · PRALUENT · Pacemakers · Plexa ProMRI · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESONATE · Ranger · Renamic Neo · Repatha · Reveal LINQ · Rivacor · SAPIEN 3 Ultra RESILIA · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $136 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
92
Per 100K population
15.6
County median income
$67,384
Nearest hospital
Adventhealth Zephyrhills
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Curkovic is a remote & electrophysiology specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Curkovic experienced with interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec?
Based on Medicare claims data, Dr. Curkovic performed 993 interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Curkovic receive payments from pharmaceutical companies?
Yes. Dr. Curkovic received a total of $12,022 from 46 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Curkovic's costs compare to other cardiovascular diseases in Zephyrhills?
Dr. Curkovic's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Curkovic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Zephyrhills
Browse cardiovascular diseases in Zephyrhills ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
CVRx, Inc. Payments to Doctors
See all physicians who received payments from CVRx, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology